Ohr Pharmaceutical, Inc. OHRP was a big mover last session with its shares rising over 10% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has gained over 41% since Dec 7.
This pharmaceutical company has witnessed one positive estimate revision in the past 30 days. The Zacks Consensus Estimate has also moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
Ohr Pharmaceutical currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.
Corcept Therapeutics Inc. CORT is another stock that warrants a look in the Med-Drugs industry. The stock also carries a Zacks Rank #1.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment